We are live on
!
Find out more
ETCM
Evolutionary Tree Capital Management Portfolio holdings
AUM
$53.2M
1-Year Est. Return
13.56%
This Fund
S&P 500
This Quarter
Est. Return
-3.13%
1 Year Est. Return
+13.56%
3 Year Est. Return
+100.03%
5 Year Est. Return
+61.7%
10 Year Est. Return
–
AUM
$77.5M
AUM Growth
-$5.56M
(-6.7%)
Cap. Flow
-$2.03M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
57.91%
Holding
37
New
2
Increased
11
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$2.44M |
| 2 |
Datadog
DDOG
|
+$1.73M |
| 3 |
Inspire Medical Systems
INSP
|
+$926K |
| 4 |
AXON
Axon Enterprise
AXON
|
+$651K |
| 5 |
Abbott
ABT
|
+$387K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.5M |
| 2 |
Charles River Laboratories
CRL
|
+$1.19M |
| 3 |
XYZ
Block Inc
XYZ
|
+$1.1M |
| 4 |
nCino
NCNO
|
+$959K |
| 5 |
CACI
CACI
|
+$891K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.76% |
| 2 | Consumer Discretionary | 18.51% |
| 3 | Healthcare | 16.86% |
| 4 | Communication Services | 6.64% |
| 5 | Financials | 6.02% |
Similar funds
WEO
NCM
TP
GMEI
FRGX
BCM
ICM
SCP
Evolutionary Tree Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Evolutionary Tree Capital Management held 37 positions worth $77.5M, down 6.7% from $83.1M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Evolutionary Tree Capital Management's Q3 2023 filing shows 2 new, 11 increased, 16 reduced and 6 closed positions. Its largest new stake was Workday: 10,530 shares worth $2.26M. The largest sale was Revance Therapeutics, Inc., an estimated $1.5M.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Evolutionary Tree Capital Management's largest Q3 2023 buy was Workday: 10,530 shares worth $2.26M.
- Evolutionary Tree Capital Management added most to Inspire Medical Systems in Q3 2023, an estimated $926K increase.
- Evolutionary Tree Capital Management's biggest Q3 2023 reduction was nCino, cutting an estimated $959K.
- Evolutionary Tree Capital Management fully exited Revance Therapeutics, Inc. in Q3 2023, selling an estimated $1.5M.
- Evolutionary Tree Capital Management's ten largest holdings make up 58% of its $77.5M portfolio in Q3 2023.
- Evolutionary Tree Capital Management opened 2 new positions and closed 6 in Q3 2023.
- Evolutionary Tree Capital Management's portfolio value fell 6.7% quarter-over-quarter to $77.5M.
Based on Evolutionary Tree Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.